INVESTOR RELATIONS
Investor relations (NASDAQ)
Stock Information
Corporate Governance
Events & Presentations
Financials & Filings
Investor Resources
Email Alerts
News and Media
Investor relations (HKEX)
CONTACT US
中文
WHO WE ARE
ABOUT Zai Lab
EXECUTIVE TEAM
BOARD OF DIRECTORS AND SCIENTIFIC ADVISORY BOARD
OUR MISSION
WHAT WE DO
DISCOVERY
DEVELOPMENT
MANUFACTURING
COMMERCIALIZATION
PARTNERING
OUR R&D
PIPELINE
SELECTED ONGOING CLINICAL TRIALS
PRODUCTS
CAREERS
WORKING AT Zai Lab
JOIN US
NEWS
PRESS RELEASE
PARTNER NEWS
MEDIA REPORTS
Combatting COVID-19 together
READ MORE
Innovation for patients withunmet medical needs worldwide
READ MORE
More time for more women
READ MORE
Using Tumor Treating Fields to fight cancer
READ MORE
NEWS
more
+
Turning Point and Zai Lab Broaden Collaboration
January 11, 2021
argenx and Zai Lab Announce Strategic Collaboration for Efgartigimod in Greater China
January 07, 2021
Zai Lab Announces Inclusion of ZEJULA® (Niraparib) in China’s National Reimbursement Drug List
December 29, 2020
About Zai Lab
Find out more
Executive Team
Find out more
Our Mission
Find out more
Pipeline
Products
Partnering